Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
02/13/2018 02/14/2018 02/15/2018 02/18/2018 02/19/2018 Date
6610(c) 6666(c) 7430(c) 7306(c) 7203 Last
1 743 557 628 670 3 086 451 262 427 435 752 Volume
-0.53% +0.85% +11.46% -1.67% -1.41% Change
More quotes
Financials ($)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
Sales 2019 19 500 M
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 1,07x
Capi. / Sales2019 1,07x
Capitalization 20 902 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products.It operates through two segments:... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
02/16BERKSHIRE HATHAWAY : Cramer shocked by Buffett's investment in "second-rate" Tev..
AQ
02/16NOVARTIS : FDA Approves Another New Generic Form of 40mg Copaxone
AQ
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
02/16BACKSTORY : Warren Buffett's Valentine's Day surprise for investors
RE
02/15Cisco Systems and Teva jump while NetApp slumps
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : closing Netanya plant, laying off 220
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : Reports 2017 Full Year and Fourth Quarter Finan..
AQ
02/15Teva Spikes on Berkshire Stake
AQ
02/15Teva jumps on Berkshire Hathaway investment
AQ
More news
Sector news : Pharmaceuticals - NEC
08:37aASTRAZENECA : Cell Lung Cancer Treatment Imfinzi Gets FDA Approval
DJ
02/18NOVARTIS : CEO Steers Drug Maker Back to R&D
DJ
02/16S&P 500 caps off strongest week in five years
RE
02/16ASTRAZENECA : U.S. FDA approves AstraZeneca's immunotherapy for lung cancer
RE
02/16NOVARTIS : readies to auction U.S. generic pills business - sources
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
02/18Teva Pharmaceutical Industries Ltd $TEVA Stake Lessened by Schroder Investmen.. 
02/18Sigma Planning Corp Acquires Shares of 11,305 Teva Pharmaceutical Industries .. 
02/17Everyone’s already heard Warren Buffett has fled his big IBM stake. But did y..
12
02/16Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate H.. 
02/16[email protected] had a #ValentinesDay surprise for investors in Teva Pharmaceu..
2
More tweets
Qtime:46
News from SeekingAlpha
01:20aTEVA : Berkshire Is Barking Up The Wrong Tree 
02/18You May Not Want To Follow Buffett Out Of Phillips 66 
02/18Tracking George Soros's Portfolio - Q4 2017 Update 
02/16Teva launches asthma treatment QVAR RediHaler in U.S. 
02/16Biotech Forum Daily Digest For January 16th 
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 18,5 $
Spread / Average Target -10%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED15.92%21 403
JOHNSON & JOHNSON-7.19%352 552
NOVARTIS-3.37%224 301
PFIZER-2.84%212 857
ROCHE HOLDING LTD.-9.37%210 327
MERCK AND COMPANY-0.50%149 572